Tuesday, 5 May 2015

Metabolomics Research and Toxicology Studies

Metabolomics - Toxicology Studies - Pharma Industry Benefits Heavily - RI Technologies' Market Research Update

In early drug development stages, Metabolomics can reduce several trial-and-error methods for pharmaceutical companies, leading to savings in costs and efforts. Metabolomics report will help Biotechnology & Healthcare Companies and Market Strategists to Identify Market Opportunities and Competition, and Know and Use Market Research for Exploring New Areas. 

For the past few years, the most commonly used methodologies in systems biology for exploring drug discovery have been genomics and proteomics. Now, metabolomics complements these two methods offering scientists a powerful tool that can uncover enormous amounts of information. The main difference between genomics/proteomics and metabolomics is that while the earlier methods studied genes and proteins, metabolomics focuses on metabolites, which are the substrates and end products of enzymatic reactions. Metabolites are compounds of low molecular weight, which determine the unique characteristics (phenotype) of an organism. This facilitates the identification of specific biological conditions, whether they are healthy or diseased.
While work on detecting and quantifying several metabolites has been continuing for decades, it is only now that scientists are able to compile a complete metabolic profile of an organism. Today research in metabolomics is directed at tracing out specific metabolites corresponding with specific disease states to facilitate drug development.
Metabolomics will make a significant impact in -
  •    Development of tools and methodology for research
  •    Bioinformatics and software to facilitate collection and analysis of data
  •    Pharmaceutical organizations involved in drug discovery and development

The report is available at  

The report gives an insight into Metabolomics Technologies – Combined/Integrated Systems, Hardware Systems for metabolic analytics and Software Systems. The study includes estimates and projections for the total global metabolomics market. Projections and estimates are also illustrated by geographic region including the United States, Europe, Japan, Asia-Pacific, Canada and Rest of World. Business profiles of 28 major companies are discussed in the report. The report serves as a guide to global metabolomics industry, covering more than 400 companies that are engaged in metabolomics R&D and supply of products and services. Major Contract Research Organizations and Universities serving metabolomics industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

About RI Technologies
RI Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.

To order this report, please contact us -

contactus@researchimpact.comAnasuya VemuriRI Technologieswww.researchimpact.com+91 9676994272
Share on  Facebook ·  Twitter ·  LinkedIn ·  Google+